Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease

Sleep Medicine

Volumn 8, Issue 6, 2007, Pages 623-636

  Wu, Ying Hui ^a   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Aging; Alzheimer's disease; Circadian rhythm; Clock genes; Light; Melatonin; Pineal gland; Suprachiasmatic nucleus

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; MELATONIN; MELATONIN 1 RECEPTOR; MESSENGER RNA; NEUROLEPTIC AGENT; NICOTINIC RECEPTOR; PLACEBO; RAMELTEON; VASOPRESSIN;

AGING; ALZHEIMER DISEASE; ARTICLE; CAUDATE NUCLEUS; CEREBROVASCULAR DISEASE; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DRUG FATALITY; FALLING; HORMONE RELEASE; HUMAN; INSOMNIA; LIGHT EXPOSURE; LOW DRUG DOSE; PHOTOTHERAPY; PHYSICAL ACTIVITY; PINEAL BODY; PRIORITY JOURNAL; PUTAMEN; SEDATION; SIDE EFFECT; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

AGING; ALZHEIMER DISEASE; BIOLOGICAL CLOCKS; CIRCADIAN RHYTHM; DISEASE PROGRESSION; HUMANS; MELATONIN; PINEAL GLAND; SLEEP DISORDERS; SUPRACHIASMATIC NUCLEUS;

EID: 34547547735     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2006.11.010     Document Type: Article

References (223)

1. Buijs R.M., and Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci 2 (2001) 521-526
2. Swaab D.F. Human hypothalamus: basic and clinical aspects. Part I. Nuclei of the human hypothalamus (2003), Elsvier, Amsterdam
3. Bliwise D.L. Sleep in normal aging and dementia. Sleep 16 (1993) 40-81
4. Van Someren E.J. Circadian and sleep disturbances in the elderly. Exp Gerontol 35 (2000) 1229-1237
5. Foley D.J., Monjan A.A., Brown S.L., Simonsick E.M., Wallace R.B., and Blazer D.G. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18 (1995) 425-432
6. Weitzman E.D., Moline M.L., Czeisler C.A., and Zimmerman J.C. Chronobiology of aging: temperature, sleep-wake rhythms and entrainment. Neurobiol Aging 3 (1982) 299-309
7. Mirmiran M., Swaab D.F., Kok J.H., Hofman M.A., Witting W., and Van Gool W.A. Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease. Prog Brain Res 93 (1992) 151-162 Discussion 62-3
8. Carrier J., Paquet J., Morettini J., and Touchette E. Phase advance of sleep and temperature circadian rhythms in the middle years of life in humans. Neurosci Lett 320 (2002) 1-4
9. Czeisler C.A., Allan J.S., Strogatz S.H., Ronda J.M., Sanchez R., Rios C.D., Freitag W.O., Richardson G.S., and Kronauer R.E. Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle. Science 233 (1986) 667-671
10. Czeisler C.A., Dumont M., Duffy J.F., Steinberg J.D., Richardson G.S., Brown E.N., Sanchez R., Rios C.D., and Ronda J.M. Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet 340 (1992) 933-936
11. Czeisler C.A., Duffy J.F., Shanahan T.L., Brown E.N., Mitchell J.F., Rimmer D.W., Ronda J.M., Silva E.J., Allan J.S., Emens J.S., Dijk D.J., and Kronauer R.E. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 284 (1999) 2177-2181
12. Duffy J.F., Dijk D.J., Klerman E.B., and Czeisler C.A. Later endogenous circadian temperature nadir relative to an earlier wake time in older people. Am J Physiol 275 (1998) R1478-R1487
13. Dijk D.J., Duffy J.F., and Czeisler C.A. Contribution of circadian physiology and sleep homeostasis to age-related changes in human sleep. Chronobiol Int 17 (2000) 285-311
14. Duffy J.F., Zeitzer J.M., Rimmer D.W., Klerman E.B., Dijk D.J., and Czeisler C.A. Peak of circadian melatonin rhythm occurs later within the sleep of older subjects. Am J Physiol Endocrinol Metab 282 (2002) E297-E303
15. Williams R.L., Karacan I., and Hursch C.J. Electroencephalography (EEG) of human sleep: clinical applications (1974), Wiley, New York
16. Habte-Gabr E., Wallace R.B., Colsher P.L., Hulbert J.R., White L.R., and Smith I.M. Sleep patterns in rural elders: demographic, health, and psychobehavioral correlates. J Clin Epidemiol 44 (1991) 5-13
17. Ancoli-Israel S. Epidemiology of sleep disorders. Clin Geriatr Med 5 (1989) 347-362
18. Huang Y.L., Liu R.Y., Wang Q.S., Van Someren E.J., Xu H., and Zhou J.N. Age-associated difference in circadian sleep-wake and rest-activity rhythms. Physiol Behav 76 (2002) 597-603
19. Carrier J., Monk T.H., Buysse D.J., and Kupfer D.J. Sleep and morningness-eveningness in the 'middle' years of life (20-59 y). J Sleep Res 6 (1997) 230-237
20. Myers B.L., and Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci Biobehav Rev 19 (1995) 553-571
21. Ohayon M.M., and Vecchierini M.F. Daytime sleepiness and cognitive impairment in the elderly population. Arch Intern Med 162 (2002) 201-208
22. Witting W., Kwa I.H., Eikelenboom P., Mirmiran M., and Swaab D.F. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry 27 (1990) 563-572
23. Bliwise D.L., Hughes M., McMahon P.M., and Kutner N. Observed sleep/wakefulness and severity of dementia in an Alzheimer's disease special care unit. J Gerontol A Biol Sci Med Sci 50 (1995) M303-M306
24. Ancoli-Israel S., Klauber M.R., Jones D.W., Kripke D.F., Martin J., Mason W., Pat-Horenczyk R., and Fell R. Variations in circadian rhythms of activity, sleep, and light exposure related to dementia in nursing-home patients. Sleep 20 (1997) 18-23
25. Bhatt M.H., Podder N., and Chokroverty S. Sleep and neurodegenerative diseases. Semin Neurol 25 (2005) 39-51
26. Prinz P.N., Vitiello M.V., Raskind M.A., and Thorpy M.J. Geriatrics: sleep disorders and aging. N Engl J Med 323 (1990) 520-526
27. McCurry S.M., Logsdon R.G., Teri L., Gibbons L.E., Kukull W.A., Bowen J.D., McCormick W.C., and Larson E.B. Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients. J Geriatr Psychiatry Neurol 12 (1999) 53-59
28. Bonanni E., Maestri M., Tognoni G., Fabbrini M., Nucciarone B., Manca M.L., Gori S., Iudice A., and Murri L. Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment. J Sleep Res 14 (2005) 311-317
29. Cardinali D.P., Brusco L.I., Liberczuk C., and Furio A.M. REVIEW. The use of melatonin in Alzheimer's disease. Neuroendocrinol Lett 23 Suppl 1 (2002) 20-23
30. Lebert F., Pasquier F., and Petit H. Sundowning syndrome in demented patients without neuroleptic therapy. Arch Gerontol Geriatr 22 (1996) 49-54
31. Volicer L., Harper D.G., Manning B.C., Goldstein R., and Satlin A. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry 158 (2001) 704-711
32. Tenover J.S., Matsumoto A.M., Clifton D.K., and Bremner W.J. Age-related alterations in the circadian rhythms of pulsatile luteinizing hormone and testosterone secretion in healthy men. J Gerontol 43 (1988) M163-M169
33. Asplund R., and Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 229 (1991) 131-134
34. Touitou Y. Effects of ageing on endocrine and neuroendocrine rhythms in humans. Horm Res 43 (1995) 12-19
35. Liu R.Y., Zhou J.N., van Heerikhuize J., Hofman M.A., and Swaab D.F. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab 84 (1999) 323-327
36. Wu Y.H., Feenstra M.G., Zhou J.N., Liu R.Y., Torano J.S., Van Kan H.J., Fischer D.F., Ravid R., and Swaab D.F. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J Clin Endocrinol Metab 88 (2003) 5898-5906
37. Magri F., Locatelli M., Balza G., Molla G., Cuzzoni G., Fioravanti M., Solerte S.B., and Ferrari E. Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging. Chronobiol Int 14 (1997) 385-396
38. Forsling M.L., Montgomery H., Halpin D., Windle R.J., and Treacher D.F. Daily patterns of secretion of neurohypophysial hormones in man: effect of age. Exp Physiol 83 (1998) 409-418
39. Mishima K., Okawa M., Satoh K., Shimizu T., Hozumi S., and Hishikawa Y. Different manifestations of circadian rhythms in senile dementia of Alzheimer's type and multi-infarct dementia. Neurobiol Aging 18 (1997) 105-109
40. Ferrari E., Arcaini A., Gornati R., Pelanconi L., Cravello L., Fioravanti M., Solerte S.B., and Magri F. Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp Gerontol 35 (2000) 1239-1250
41. Mishima K., Tozawa T., Satoh K., Matsumoto Y., Hishikawa Y., and Okawa M. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol Psychiatry 45 (1999) 417-421
42. Bixler E.O., Kales A., Soldatos C.R., Kales J.D., and Healey S. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 136 (1979) 1257-1262
43. Jensen E., Dehlin O., Hagberg B., Samuelsson G., and Svensson T. Insomnia in an 80-year-old population: relationship to medical, psychological and social factors. J Sleep Res 7 (1998) 183-189
44. Maggi S., Langlois J.A., Minicuci N., Grigoletto F., Pavan M., Foley D.J., and Enzi G. Sleep complaints in community-dwelling older persons: prevalence, associated factors, and reported causes. J Am Geriatr Soc 46 (1998) 161-168
45. Irwin M., McClintick J., Costlow C., Fortner M., White J., and Gillin J.C. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J 10 (1996) 643-653
46. Moe K.E., Vitiello M.V., Larsen L.H., and Prinz P.N. Symposium: cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J Sleep Res 4 (1995) 15-20
47. Briones B., Adams N., Strauss M., Rosenberg C., Whalen C., Carskadon M., Roebuck T., Winters M., and Redline S. Relationship between sleepiness and general health status. Sleep 19 (1996) 583-588
48. Whitney C.W., Enright P.L., Newman A.B., Bonekat W., Foley D., and Quan S.F. Correlates of daytime sleepiness in 4578 elderly persons: the Cardiovascular Health Study. Sleep 21 (1998) 27-36
49. Newman A.B., Enright P.L., Manolio T.A., Haponik E.F., and Wahl P.W. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the Cardiovascular Health Study. J Am Geriatr Soc 45 (1997) 1-7
50. Chilcott L.A., and Shapiro C.M. The socioeconomic impact of insomnia. An overview. Pharmacoeconomics 10 Suppl 1 (1996) 1-14
51. Rabins P.V., Mace N.L., and Lucas M.J. The impact of dementia on the family. JAMA 248 (1982) 333-335
52. Gallagher-Thompson D., Brooks III J.O., Bliwise D., Leader J., and Yesavage J.A. The relations among caregiver stress, sundowning symptoms, and cognitive decline in Alzheimer's disease. J Am Geriatr Soc 40 (1992) 807-810
53. Ballard C.G., Eastwood C., Gahir M., and Wilcock G. A follow up study of depression in the carers of dementia sufferers. Bmj 312 (1996) 947
54. Pollak C.P., and Perlick D. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 4 (1991) 204-210
55. Bianchetti A., Scuratti A., Zanetti O., Binetti G., Frisoni G.B., Magni E., and Trabucchi M. Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. Dementia 6 (1995) 108-112
56. Moran M., Lynch C.A., Walsh C., Coen R., Coakley D., and Lawlor B.A. Sleep disturbance in mild to moderate Alzheimer's disease. Sleep Med 6 (2005) 347-352
57. Hofman M.A., and Swaab D.F. Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. J Biol Rhythms 8 (1993) 283-295
58. Scully R.E., Mark E.J., and McNeeley B.U. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-1983. A 55-year-old woman with diabetes insipidus and a suprasellar mass. N Engl J Med 309 (1983) 418-425
59. Schwartz W.J., Busis N.A., and Hedley-Whyte E.T. A discrete lesion of ventral hypothalamus and optic chiasm that disturbed the daily temperature rhythm. J Neurol 233 (1986) 1-4
60. Cohen R.A., and Albers H.E. Disruption of human circadian and cognitive regulation following a discrete hypothalamic lesion: a case study. Neurology 41 (1991) 726-729
61. Moore R.Y. The fourth C.U. Ariens Kappers lecture. The organization of the human circadian timing system. Prog Brain Res 93 (1992) 99-115 discussion 15-7
62. Haugh R.M., and Markesbery W.R. Hypothalamic astrocytoma. Syndrome of hyperphagia, obesity, and disturbances of behavior and endocrine and autonomic function. Arch Neurol 40 (1983) 560-563
63. Abrahamson E.E., and Moore R.Y. Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res 916 (2001) 172-191
64. Schwartz W.J., Lydic R., and Moore-Ede M.C. In vivo metabolic activity of the suprachiasmatic nuclei: non-uniform intranuclear distribution of 14C-labeled deoxyglucose uptake. Brain Res 424 (1987) 249-257
65. Ingram C.D., Ciobanu R., Coculescu I.L., Tanasescu R., Coculescu M., and Mihai R. Vasopressin neurotransmission and the control of circadian rhythms in the suprachiasmatic nucleus. Prog Brain Res 119 (1998) 351-364
66. Tousson E., and Meissl H. Suprachiasmatic nuclei grafts restore the circadian rhythm in the paraventricular nucleus of the hypothalamus. J Neurosci 24 (2004) 2983-2988
67. Kalsbeek A., van Heerikhuize J.J., Wortel J., and Buijs R.M. A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. J Neurosci 16 (1996) 5555-5565
68. Hofman M.A., and Swaab D.F. Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res 651 (1994) 134-142
69. Zhou J.N., Hofman M.A., and Swaab D.F. VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging 16 (1995) 571-576
70. Hofman M.A., and Swaab D.F. Influence of aging on the seasonal rhythm of the vasopressin-expressing neurons in the human suprachiasmatic nucleus. Neurobiol Aging 16 (1995) 965-971
71. Swaab D.F., Fliers E., and Partiman T.S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res 342 (1985) 37-44
72. Swaab D.F., Roozendaal B., Ravid R., Velis D.N., Gooren L., and Williams R.S. Suprachiasmatic nucleus in aging, Alzheimer's disease, transsexuality and Prader-Willi syndrome. Prog Brain Res 72 (1987) 301-310
73. Zhou J.N., and Swaab D.F. Activation and degeneration during aging: a morphometric study of the human hypothalamus. Microsc Res Tech 44 (1999) 36-48
74. Nygard M., and Palomba M. The GABAergic network in the suprachiasmatic nucleus as a key regulator of the biological clock: does it change during senescence?. Chronobiol Int 23 (2006) 427-435
75. Stopa E.G., Volicer L., Kuo-Leblanc V., Harper D., Lathi D., Tate B., and Satlin A. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 58 (1999) 29-39
76. Swaab D.F., Grundke-Iqbal I., Iqbal K., Kremer H.P., Ravid R., and van de Nes J.A. Tau and ubiquitin in the human hypothalamus in aging and Alzheimer's disease. Brain Res 590 (1992) 239-249
77. Van de Nes J.A., Sluiter A.A., Pool C.W., Kamphorst W., Ravid R., and Swaab D.F. The monoclonal antibody Alz-50, used to reveal cytoskeletal changes in Alzheimer's disease, also reacts with a large subpopulation of somatostatin neurons in the normal human hypothalamus and adjoining areas. Brain Res 655 (1994) 97-109
78. Van de Nes J.A., Kamphorst W., Ravid R., and Swaab D.F. Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol (Berl) 96 (1998) 129-138
79. Liu R.Y., Zhou J.N., Hoogendijk W.J., van Heerikhuize J., Kamphorst W., Unmehopa U.A., Hofman M.A., and Swaab D.F. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol 59 (2000) 314-322
80. Wu Y.H., Fischer D.F., Kalsbeek A., Garidou-Boof M.L., van der Vliet J., van Heijningen C., Liu R.Y., Zhou J.N., and Swaab D.F. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the master clock. FASEB J 20 (2006) 1874-1876
81. Zhou J.N., Liu R.Y., Kamphorst W., Hofman M.A., and Swaab D.F. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res 35 (2003) 125-130
82. Reppert S.M., and Weaver D.R. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63 (2001) 647-676
83. Whitmore D., Cermakian N., Crosio C., Foulkes N.S., Pando M.P., Travnickova Z., and Sassone-Corsi P. A clockwork organ. Biol Chem 381 (2000) 793-800
84. Asai M., Yoshinobu Y., Kaneko S., Mori A., Nikaido T., Moriya T., Akiyama M., and Shibata S. Circadian profile of Per gene mRNA expression in the suprachiasmatic nucleus, paraventricular nucleus, and pineal body of aged rats. J Neurosci Res 66 (2001) 1133-1139
85. Kolker D.E., Fukuyama H., Huang D.S., Takahashi J.S., Horton T.H., and Turek F.W. Aging alters circadian and light-induced expression of clock genes in golden hamsters. J Biol Rhythms 18 (2003) 159-169
86. Yamazaki S., Straume M., Tei H., Sakaki Y., Menaker M., and Block G.D. Effects of aging on central and peripheral mammalian clocks. Proc Natl Acad Sci USA 99 (2002) 10801-10806
87. Kolker D.E., Vitaterna M.H., Fruechte E.M., Takahashi J.S., and Turek F.W. Effects of age on circadian rhythms are similar in wild-type and heterozygous Clock mutant mice. Neurobiol Aging 25 (2004) 517-523
88. Oster H., Baeriswyl S., Van Der Horst G.T., and Albrecht U. Loss of circadian rhythmicity in aging mPer1-/-mCry2-/- mutant mice. Genes Dev 17 (2003) 1366-13379
89. Claustrat B., Brun J., and Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 9 (2005) 11-24
90. Kunieda T., Minamino T., Katsuno T., Tateno K., Nishi J., Miyauchi H., Orimo M., Okada S., and Komuro I. Cellular senescence impairs circadian expression of clock genes in vitro and in vivo. Circ Res 98 (2006) 532-539
91. Arendt J. Melatonin and the mammalian pineal gland (1995), Chapman&Hall, London
92. Dubocovich M.L., Rivera-Bermudez M.A., Gerdin M.J., and Masana M.I. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 8 (2003) d1093-d1108
93. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., and Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 92 (1995) 8734-8738
94. Reppert S.M., Weaver D.R., and Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13 (1994) 1177-1185
95. Liu C., Weaver D.R., Jin X., Shearman L.P., Pieschl R.L., Gribkoff V.K., and Reppert S.M. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19 (1997) 91-102
96. Weaver D.R., and Reppert S.M. The Mel1a melatonin receptor gene is expressed in human suprachiasmatic nuclei. Neuroreport 8 (1996) 109-112
97. Thomas L., Purvis C.C., Drew J.E., Abramovich D.R., and Williams L.M. Melatonin receptors in human fetal brain: 2-[(125)I]iodomelatonin binding and MT1 gene expression. J Pineal Res 33 (2002) 218-224
98. Reppert S.M., Weaver D.R., Rivkees S.A., and Stopa E.G. Putative melatonin receptors in a human biological clock. Science 242 (1988) 78-81
99. Wu Y.H., Zhou J.N., Balesar R., Bao A.M., Unmehopa U.A., Jockers R., Van Heerikhuize J., and Swaab D.F. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone. Comp Neurol (2006)
100. Wu Y.H., Zhou J.N., Van Heerikhuize J., Jockers R., and Swaab D.F. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease. Neurobiol Aging (2006)
101. Mazzucchelli C., Pannacci M., Nonno R., Lucini V., Fraschini F., and Stankov B.M. The melatonin receptor in the human brain: cloning experiments and distribution studies. Brain Res Mol Brain Res 39 (1996) 117-126
102. Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother (2006)
103. Skene D.J., and Swaab D.F. Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp Gerontol 38 (2003) 199-206
104. Wu Y.H., and Swaab D.F. The human pineal gland and melatonin in aging and Alzheimer's disease. J Pineal Res 38 (2005) 145-152
105. Zhou J.N., Liu R.Y., Van Heerikhuize J., Hofman M.A., and Swaab D.F. Alterations in the circadian rhythm of salivary melatonin begin during middle-age. J Pineal Res 34 (2003) 11-16
106. Zeitzer J.M., Daniels J.E., Duffy J.F., Klerman E.B., Shanahan T.L., Dijk D.J., and Czeisler C.A. Do plasma melatonin concentrations decline with age?. Am J Med 107 (1999) 432-436
107. Kawinska A., Dumont M., Selmaoui B., Paquet J., and Carrier J. Are modifications of melatonin circadian rhythm in the middle years of life related to habitual patterns of light exposure?. J Biol Rhythms 20 (2005) 451-460
108. Rousseau A., Petren S., Plannthin J., Eklundh T., and Nordin C. Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers. J Neural Transm 106 (1999) 883-888
109. Reiter R.J., Tan D.X., Manchester L.C., and El-Sawi M.R. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann NY Acad Sci 959 (2002) 238-250
110. Reiter R.J., Tan D.X., Osuna C., and Gitto Ea. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 7 (2000) 444-458
111. Pappolla M.A., Chyan Y.J., Poeggeler B., Frangione B., Wilson G., Ghiso J., and Reiter R.J. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J Neural Transm 107 (2000) 203-231
112. Pappolla M.A., Chyan Y.J., Poeggeler B., Bozner P., Ghiso J., LeDoux S.P., and Wilson G.L. Alzheimer beta protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin. J Pineal Res 27 (1999) 226-229
113. Feng Z., and Zhang J.T. Melatonin reduces amyloid beta-induced apoptosis in pheochromocytoma (PC12) cells. J Pineal Res 37 (2004) 257-266
114. Matsubara E., Bryant-Thomas T., Pacheco Quinto J., Henry T.L., Poeggeler B., Herbert D., Cruz-Sanchez F., Chyan Y.J., Smith M.A., Perry G., Shoji M., Abe K., Leone A., Grundke-Ikbal I., Wilson G.L., Ghiso J., Williams C., Refolo L.M., and Pappolla M.A. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem 85 (2003) 1101-1108
115. Wang J.Z., and Wang Z.F. Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol Sin 27 (2006) 41-49
116. Zhu L.Q., Wang S.H., Ling Z.Q., Wang D.L., and Wang J.Z. Effect of inhibiting melatonin biosynthesis on spatial memory retention and tau phosphorylation in rat. J Pineal Res 37 (2004) 71-77
117. Gusek W. Histology of the pineal gland in the elderly human. Aktuelle Gerontol 13 (1983) 111-114
118. Humbert W., and Pevet P. Calcium concretions in the pineal gland of aged rats: an ultrastructural and microanalytical study of their biogenesis. Cell Tissue Res 279 (1995) 565-573
119. Kunz D., Bes F., Schlattmann P., and Herrmann W.M. On pineal calcification and its relation to subjective sleep perception: a hypothesis-driven pilot study. Psychiatry Res 82 (1998) 187-191
120. Schmid H.A., Requintina P.J., Oxenkrug G.F., and Sturner W. Calcium, calcification, and melatonin biosynthesis in the human pineal gland: a postmortem study into age-related factors. J Pineal Res 16 (1994) 178-183
121. Bojkowski C.J., and Arendt J. Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects. Clin Endocrinol (Oxf) 33 (1990) 435-444
122. Kunz D., Schmitz S., Mahlberg R., Mohr A., Stoter C., Wolf K.J., and Herrmann W.M. A new concept for melatonin deficit: on pineal calcification and melatonin excretion. Neuropsychopharmacology 21 (1999) 765-772
123. Otani T., Gyorkey F., and Farrell G. Enzymes of the human pineal body. J Clin Endocrinol Metab 28 (1968) 349-354
124. Pardo C.A., Martin L.J., Troncoso J.C., and Price D.L. The human pineal gland in aging and Alzheimer's disease: patterns of cytoskeletal antigen immunoreactivity. Acta Neuropathol (Berl) 80 (1990) 535-540
125. Tapp E., and Huxley M. The histological appearance of the human pineal gland from puberty to old age. J Pathol 108 (1972) 137-144
126. Arieti S. The pineal gland in old age. J Neuropathol Exp Neurol 13 (1954) 482-491
127. Jengeleski C.A., Powers R.E., O'Connor D.T., and Price D.L. Noradrenergic innervation of human pineal gland: abnormalities in aging and Alzheimer's disease. Brain Res 481 (1989) 378-382
128. Friedland R.P., Luxenberg J.S., and Koss E. A quantitative study of intracranial calcification in dementia of the Alzheimer type. Int Psychogeriatr 2 (1990) 36-43
129. Namihira M., Honma S., Abe H., Tanahashi Y., Ikeda M., and Honma K. Daily variation and light responsiveness of mammalian clock gene, Clock and BMAL1, transcripts in the pineal body and different areas of brain in rats. Neurosci Lett 267 (1999) 69-72
130. Takekida S., Yan L., Maywood E.S., Hastings M.H., and Okamura H. Differential adrenergic regulation of the circadian expression of the clock genes Period1 and Period2 in the rat pineal gland. Eur J Neurosci 12 (2000) 4557-4561
131. Fukuhara C., Dirden J.C., and Tosini G. Circadian expression of period 1, period 2, and arylalkylamine N-acetyltransferase mRNA in the rat pineal gland under different light conditions. Neurosci Lett 286 (2000) 167-170
132. Von Gall C., Schneider-Huther I., Pfeffer M., Dehghani F., Korf H.W., and Stehle J.H. Clock gene protein mPER1 is rhythmically synthesized and under cAMP control in the mouse pineal organ. J Neuroendocrinol 13 (2001) 313-316
133. Simonneaux V., Poirel V.J., Garidou M.L., Nguyen D., Diaz-Rodriguez E., and Pevet P. Daily rhythm and regulation of clock gene expression in the rat pineal gland. Brain Res Mol Brain Res 120 (2004) 164-172
134. Lockley S.W., Skene D.J., James K., Thapan K., Wright J., and Arendt J. Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol 164 (2000) R1-R6
135. Sack R.L., Brandes R.W., Kendall A.R., and Lewy A.J. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 343 (2000) 1070-1077
136. Skene D.J. Optimization of light and melatonin to phase-shift human circadian rhythms. J Neuroendocrinol 15 (2003) 438-441
137. Arendt J., Skene D.J., Middleton B., Lockley S.W., and Deacon S. Efficacy of melatonin treatment in jet lag, shift work, and blindness. J Biol Rhythms 12 (1997) 604-617
138. Klerman E.B., Rimmer D.W., Dijk D.J., Kronauer R.E., and Rizzo J.F. 3rd and Czeisler, CA. Nonphotic entrainment of the human circadian pacemaker. Am J Physiol 274 (1998) R991-R996
139. Duffy J.F., Zeitzer J.M., and Czeisler C.A. Decreased sensitivity to phase-delaying effects of moderate intensity light in older subjects. Neurobiol Aging (2006)
140. Herljevic M., Middleton B., Thapan K., and Skene D.J. Light-induced melatonin suppression: age-related reduction in response to short wavelength light. Exp Gerontol 40 (2005) 237-242
141. Shochat T., Martin J., Marler M., and Ancoli-Israel S. Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res 9 (2000) 373-379
142. Mishima K., Okawa M., Shimizu T., and Hishikawa Y. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J Clin Endocrinol Metab 86 (2001) 129-134
143. Van Someren E.J., Hagebeuk E.E., Lijzenga C., Scheltens P., de Rooij S.E., Jonker C., Pot A.M., Mirmiran M., and Swaab D.F. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry 40 (1996) 259-270
144. Campbell S.S., Kripke D.F., Gillin J.C., and Hrubovcak J.C. Exposure to light in healthy elderly subjects and Alzheimer's patients. Physiol Behav 42 (1988) 141-144
145. Sperduto R.D., Hiller R., and Seigel D. Lens opacities and senile maculopathy. Arch Ophthalmol 99 (1981) 1004-1008
146. Hirvela H., and Laatikainen L. Visual acuity in a population aged 70 years or older; prevalence and causes of visual impairment. Acta Ophthalmol Scand 73 (1995) 99-104
147. Klaver C.C., Ott A., Hofman A., Assink J.J., Breteler M.M., and de Jong P.T. Is age-related maculopathy associated with Alzheimer's Disease? The Rotterdam Study. Am J Epidemiol 150 (1999) 963-968
148. Hinton D.R., Sadun A.A., Blanks J.C., and Miller C.A. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 315 (1986) 485-487
149. Katz B., Rimmer S., Iragui V., and Katzman R. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?. Ann Neurol 26 (1989) 221-225
150. Trick G.L., Barris M.C., and Bickler-Bluth M. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann Neurol 26 (1989) 226-231
151. Blanks J.C., Schmidt S.Y., Torigoe Y., Porrello K.V., Hinton D.R., and Blanks R.H. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 17 (1996) 385-395
152. Blanks J.C., Torigoe Y., Hinton D.R., and Blanks R.H. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 17 (1996) 377-384
153. Bayer A.U., and Ferrari F. Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease. Eye 16 (2002) 209-212
154. Bayer A.U., Ferrari F., and Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 47 (2002) 165-168
155. Barnes L.L., Mendes de Leon C.F., Wilson R.S., Bienias J.L., and Evans D.A. Social resources and cognitive decline in a population of older African Americans and whites. Neurology 63 (2004) 2322-2326
156. Laurin D., Verreault R., Lindsay J., MacPherson K., and Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58 (2001) 498-504
157. Monane M. Insomnia in the elderly. J Clin Psychiatry 53 Suppl (1992) 23-28
158. Van Someren E.J., Mirmiran M., and Swaab D.F. Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: chronobiological perspectives. Behav Brain Res 57 (1993) 235-253
159. Monane M., Glynn R.J., and Avorn J. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents. Clin Pharmacol Ther 59 (1996) 83-92
160. Glass J., Lanctot K.L., Herrmann N., Sproule B.A., and Busto U.E. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Bmj 331 (2005) 1169
161. Ray W.A., Griffin M.R., and Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 262 (1989) 3303-3307
162. Burney-Puckett M. Sundown syndrome: etiology and management. J Psychosoc Nurs Ment Health Serv 34 (1996) 40-43
163. Mendelson W.B. Clinical distinctions between long-acting and short-acting benzodiazepines. J Clin Psychiatry 53 Suppl (1992) 4-7 discussion 8-9
164. Wirz-Justice A., Werth E., Savaskan E., Knoblauch V., Gasio P.F., and Muller-Spahn F. Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease. Alzheimer Dis Assoc Disord 14 (2000) 212-215
165. Wooltorton E. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. Cmaj 167 (2002) 1269-1270
166. Wooltorton E. Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials. Cmaj 170 (2004) 1395
167. FDA. US Food and Drug Administration. Safety data on Zyprexa (olanzapine): hyperglycemia and diabetes. Available at: http://www.fda.gov/medwatch/SAFETY/2004/zyprexa.htm. Accessibility verified September 6, 2005. 2005.
168. McShane R., Keene J., Gedling K., Fairburn C., Jacoby R., and Hope T. Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. Bmj 314 (1997) 266-270
169. Ballard C.G., Perry R.H., McKeith I.G., and Perry E.K. Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies. Int J Geriatr Psychiatry 20 (2005) 872-875
170. Singh S., and Wooltorton E. Increased mortality among elderly patients with dementia using atypical antipsychotics. Cmaj 173 (2005) 252
171. Court J.A., Piggott M.A., Lloyd S., Cookson N., Ballard C.G., McKeith I.G., Perry R.H., and Perry E.K. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 98 (2000) 79-87
172. FDA. US Food and Drug Administration. 5 FDA Public Health Advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. Available at: http://www.fda.gov/cder/drug/advisory/antipsychotics.htm. Accessed April 13, 2005. 2005.
173. Schneider L.S., Dagerman K.S., and Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294 (2005) 1934-1943
174. Garfinkel D., Laudon M., Nof D., and Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 346 (1995) 541-544
175. Hughes R.J., and Badia P. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep 20 (1997) 124-131
176. Hughes R.J., Sack R.L., and Lewy A.J. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep 21 (1998) 52-68
177. Haimov I., Lavie P., Laudon M., Herer P., Vigder C., and Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep 18 (1995) 598-603
178. Garfinkel D., Laudon M., and Zisapel N. Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs. Arch Gerontol Geriatr 24 (1997) 223-231
179. Wurtman R.J., and Zhdanova I. Improvement of sleep quality by melatonin. Lancet 346 (1995) 1491
180. Campbell S.S., Dawson D., and Anderson M.W. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc 41 (1993) 829-836
181. Mishima K., Okawa M., Hishikawa Y., Hozumi S., Hori H., and Takahashi K. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 89 (1994) 1-7
182. Lovell B.B., Ancoli-Israel S., and Gevirtz R. Effect of bright light treatment on agitated behavior in institutionalized elderly subjects. Psychiatry Res 57 (1995) 7-12
183. Murphy P.J., and Campbell S.S. Enhanced performance in elderly subjects following bright light treatment of sleep maintenance insomnia. J Sleep Res 5 (1996) 165-172
184. Van Someren E.J., Kessler A., Mirmiran M., and Swaab D.F. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 41 (1997) 955-963
185. Van Someren E.J. More than a marker: interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities. Chronobiol Int 17 (2000) 313-354
186. King A.C., Oman R.F., Brassington G.S., Bliwise D.L., and Haskell W.L. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA 277 (1997) 32-37
187. Van Someren E.J., Lijzenga C., Mirmiran M., and Swaab D.F. Long-term fitness training improves the circadian rest-activity rhythm in healthy elderly males. J Biol Rhythms 12 (1997) 146-156
188. Jean-Louis G., von Gizycki H., and Zizi F. Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 25 (1998) 177-183
189. Andrade C., Srihari B.S., Reddy K.P., and Chandramma L. Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study. J Clin Psychiatry 62 (2001) 41-45
190. Zhdanova I.V., Wurtman R.J., Regan M.M., Taylor J.A., Shi J.P., and Leclair O.U. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab 86 (2001) 4727-4730
191. Dawson D., Rogers N.L., van den Heuvel C.J., Kennaway D.J., and Lushington K. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs. J Biol Rhythms 13 (1998) 532-538
192. Baskett J.J., Broad J.B., Wood P.C., Duncan J.R., Pledger M.J., English J., and Arendt J. Does melatonin improve sleep in older people? A randomised crossover trial. Age Ageing 32 (2003) 164-170
193. Brusco L.I., Marquez M., and Cardinali D.P. Monozygotic twins with Alzheimer's disease treated with melatonin: Case report. J Pineal Res 25 (1998) 260-263
194. Brusco L.I., Fainstein I., Marquez M., and Cardinali D.P. Effect of melatonin in selected populations of sleep-disturbed patients. Biol Signals Recept 8 (1999) 126-131
195. Asayama K., Yamadera H., Ito T., Suzuki H., Kudo Y., and Endo S. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch 70 (2003) 334-341
196. Mahlberg R., Kunz D., Sutej I., Kuhl K.P., and Hellweg R. Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. J Clin Psychopharmacol 24 (2004) 456-459
197. Singer C., Tractenberg R.E., Kaye J., Schafer K., Gamst A., Grundman M., Thomas R., and Thal L.J. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 26 (2003) 893-901
198. Brusco L.I., Marquez M., and Cardinali D.P. Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease. Neuroendocrinol Lett 21 (2000) 39-42
199. Peck J.S., LeGoff D.B., Ahmed I., and Goebert D. Cognitive effects of exogenous melatonin administration in elderly persons: a pilot study. Am J Geriatr Psychiatry 12 (2004) 432-436
200. Jansen S.L., Forbes D.A., Duncan V., and Morgan D.G. Melatonin for cognitive impairment. Cochrane Database Syst Rev (2006) CD003802
201. Roth T., Seiden D., Sainati S., Wang-Weigand S., Zhang J., and Zee P. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med 7 (2006) 312-318
202. Erman M., Seiden D., Zammit G., Sainati S., and Zhang J. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med 7 (2006) 17-24
203. Wurtman R. Ramelteon: a novel treatment for the treatment of insomnia. Expert Rev Neurother 6 (2006) 957-964
204. Rea M.A. Photic entrainment of circadian rhythms in rodents. Chronobiol Int 15 (1998) 395-423
205. Lucassen P.J., Hofman M.A., and Swaab D.F. Increased light intensity prevents the age related loss of vasopressin-expressing neurons in the rat suprachiasmatic nucleus. Brain Res 693 (1995) 261-266
206. Van Someren E.J., Riemersma R.F., and Swaab D.F. Functional plasticity of the circadian timing system in old age: light exposure. Prog Brain Res 138 (2002) 205-231
207. Mishima K., Okawa M., Hozumi S., and Hishikawa Y. Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons. Chronobiol Int 17 (2000) 419-432
208. Ohashi Y., Okamoto N., Uchida K., Iyo M., Mori N., and Morita Y. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. Biol Psychiatry 45 (1999) 1646-1652
209. Kohsaka M., Fukuda N., Honma H., Kobayashi R., Sakakibara S., Koyama E., Nakano T., and Matsubara H. Effects of moderately bright light on subjective evaluations in healthy elderly women. Psychiatry Clin Neurosci 53 (1999) 239-241
210. Okawa M., Mishima K., Hishikawa Y., Hozumi S., Hori H., and Takahashi K. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep 14 (1991) 478-485
211. Okawa M., Mishima K., Shirakawa K., Hishikawa Y., Huzomi S., and Hori H. Sleep disorders in elderly patients with dementia and attempts of bright light therapy in senile dementia of Alzheimer's type and multi-infarct dementia (1994), Hokkaido University Press, Sapporo
212. Satlin A., Volicer L., Ross V., Herz L., and Campbell S. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. Am J Psychiatry 149 (1992) 1028-1032
213. Okumoto Y., Koyama E., Matsubara H., Nakano T., and Nakamura R. Sleep improvement by light in a demented aged individual. Psychiatry Clin Neurosci 52 (1998) 194-196
214. Van Someren E.J. Rest-activity rhythms in aging, Alzheimer's disease and Parkinson's disease. Method DevelopTher Intervent (1997)
215. Lyketsos C.G., Lindell Veiel L., Baker A., and Steele C. A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care. Int J Geriatr Psychiatry 14 (1999) 520-525
216. Dowling G.A., Hubbard E.M., Mastick J., Luxenberg J.S., Burr R.L., and Van Someren E.J. Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease. Int Psychogeriatr 17 (2005) 221-236
217. Dowling G.A., Mastick J., Hubbard E.M., Luxenberg J.S., and Burr R.L. Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. Int J Geriatr Psychiatry 20 (2005) 738-743
218. Colenda C.C., Cohen W., McCall W.V., and Rosenquist P.B. Phototherapy for patients with Alzheimer disease with disturbed sleep patterns: results of a community-based pilot study. Alzheimer Dis Assoc Disord 11 (1997) 175-178
219. Teri L., Gibbons L.E., McCurry S.M., Logsdon R.G., Buchner D.M., Barlow W.E., Kukull W.A., LaCroix A.Z., McCormick W., and Larson E.B. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA 290 (2003) 2015-2022
220. Werth E., Savaskan E., Knoblauch V., Gasio P.F., van Someren E.J., Hock C., and Wirz-Justice A. Decline in long-term circadian rest-activity cycle organization in a patient with dementia. J Geriatr Psychiatry Neurol 15 (2002) 55-59
221. Van Someren E.J., Scherder E.J., and Swaab D.F. Transcutaneous electrical nerve stimulation (TENS) improves circadian rhythm disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord 12 (1998) 114-118
222. Scherder E.J., Van Someren E.J., and Swaab D.F. Transcutaneous electrical nerve stimulation (TENS) improves the rest-activity rhythm in midstage Alzheimer's disease. Behav Brain Res 101 (1999) 105-107
223. Spence D.W., Kayumov L., Chen A., Lowe A., Jain U., Katzman M.A., Shen J., Perelman B., and Shapiro C.M. Acupuncture increases nocturnal melatonin secretion and reduces insomnia and anxiety: a preliminary report. J Neuropsychiatry Clin Neurosci 16 (2004) 19-28